Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision label updated from v3.6.4 to v3.6.5, indicating a minor update to the underlying platform.SummaryDifference0.0%

- Check18 days agoChange DetectedThe study's results status label changed from 'No Results Posted' to 'Results Submitted', indicating that the trial's results have been submitted for reporting and are awaiting posting.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4. This indicates a new build of the page without affecting the study data or displayed content.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page footer now shows Revision: v3.6.3, indicating a platform update that affects the interface but not the clinical trial details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a revision stamp update from v3.6.0 to v3.6.2, indicating a small deployment update.SummaryDifference0.0%

- Check61 days agoChange DetectedDeleted items remove the drug Pembrolizumab and several lymphoma-related disease terms from the page, altering the study's described intervention and target conditions. These removals also affect how the study is indexed and understood by users seeking details about treatment and eligibility.SummaryDifference18%

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.